Methodology of clinical drug trials /

Saved in:
Bibliographic Details
Author / Creator:Spriet, Alain
Uniform title:Méthodologie des essais cliniques des médicaments. English
Edition:2nd, rev. ed.
Imprint:Basel ; New York : Karger, c1994.
Description:viii, 269 p. : ill. ; 25 cm.
Language:English
Subject:Drugs -- Testing -- Methodology.
Clinical Trials -- methods
Drug Evaluation -- methods
Drugs -- Testing -- Methodology.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/1617902
Hidden Bibliographic Details
Other authors / contributors:Dupin-Spriet, Thérèse
Simon, Pierre, M.D.
ISBN:3805558562
Notes:Includes bibliographical references and index.
committed to retain 20170930 20421213 HathiTrust
LEADER 03026cam a2200505 a 4500
001 1617902
003 ICU
005 20020106120600.0
008 940520s1994 sz a b 001 0 eng d
010 |a  94136937 
020 |a 3805558562 
035 |a (ICU)BID18673837 
035 |a (OCoLC)29772304 
040 |a MWMU  |c MWMU  |d DLC$dOrLoB 
041 1 |a eng  |h fre 
042 |a lccopycat 
050 0 0 |a RM301.27  |b .S6813 1994 
060 0 |a QV 771  |b S769m 1994a 
082 |a 615/.1901  |2 20 
100 1 |a Spriet, Alain  |0 http://id.loc.gov/authorities/names/n84133824  |1 http://viaf.org/viaf/7397229 
240 1 0 |a Méthodologie des essais cliniques des médicaments.  |l English 
245 1 0 |a Methodology of clinical drug trials /  |c Alain Spriet, Thérèse Dupin-Spriet, Pierre Simon ; translated by Robert Coluzzi ... [et al.] ; with a preface by Fernand Sauer. 
250 |a 2nd, rev. ed. 
260 |a Basel ;  |a New York :  |b Karger,  |c c1994. 
300 |a viii, 269 p. :  |b ill. ;  |c 25 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Introduction --  |g 2.  |t Principles of the controlled trial --  |g 3.  |t Selection of subjects --  |g 4.  |t Efficacy assessment --  |g 5.  |t Randomization --  |g 6.  |t Single-blind and double-blind trials --  |g 7.  |t Choice of the comparator: placebo or active drug? --  |g 8.  |t Dosage and therapeutic schema --  |g 9.  |t Experimental designs --  |g 10.  |t Subjects lost to follow-up --  |g 11.  |t Patient compliance and discontinuation of treatment --  |g 12.  |t Case report forms --  |g 13.  |t Multicenter trials --  |g 14.  |t Imperfect data analysis --  |g 15.  |t Confirmatory analysis of the principal evaluation criterion --  |g 16.  |t Interim analyses --  |g 17.  |t Exploratory analyses --  |g 18.  |t Pragmatic trials. Decision methods --  |g 19.  |t Safety data --  |g 20.  |t Sample size --  |g 21.  |t Prudence and protection of participants --  |g 22.  |t Preparing a protocol --  |g 23.  |t Index. 
583 1 |a committed to retain  |c 20170930  |d 20421213  |f HathiTrust  |5 ICU 
650 0 |a Drugs  |x Testing  |x Methodology. 
650 2 |a Clinical Trials  |x methods 
650 2 |a Drug Evaluation  |x methods 
650 7 |a Drugs  |x Testing  |x Methodology.  |2 fast  |0 http://id.worldcat.org/fast/fst00898947 
700 2 0 |a Dupin-Spriet, Thérèse  |0 http://id.loc.gov/authorities/names/n92102774  |1 http://viaf.org/viaf/32037688 
700 1 0 |a Simon, Pierre,  |c M.D.  |0 http://id.loc.gov/authorities/names/n84133825  |1 http://viaf.org/viaf/189397871 
850 |a ICU 
901 |a ToCBNA 
903 |a HeVa 
903 |a Hathi 
929 |a cat 
999 f f |i 172c45d0-137d-5565-a2b8-89e605afc5b4  |s cdb47dcc-f045-5ee1-a834-1b4dbcb18989 
928 |t Library of Congress classification  |a RM301.27.S68130 1994  |l JCL  |c JCL-Sci  |i 2750231 
927 |t Library of Congress classification  |a RM301.27.S68130 1994  |l JCL  |c JCL-Sci  |e CRERAR  |b 39835184  |i 3063922